dear colleaques!!!

F

fersah

Member
Joined
May 28, 2009
Messages
32
Reaction score
0
Points
6
Turkey
Dear friends I need these articles.


  1. Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. Gerros TC, Semrad SD, Proctor RA, LaBorde A. Am J Vet Res. 1993 Dec;54(12):2121-7.


  1. Serum cytokine levels evaluated in neonatal calves in relation to disease incidence up to 4 months after colostrum ingestion. HIRAKO TSUYOSHI HISAEDA KEIICHI, IZUMI KEN'ICHI, KUROSAWA TAKASHI, HAGIWARA KATSURO, KIRISAWA RIKIO IWAI HIROSHI. Journal of Rakuno Gakuen University. Natural Science. (2005),VOL.29;NO.2;PAGE.171-175.


  1. Yamanaka H, Hagiwara K, Kirisawa R, Iwai H. Transient detection of proinflammatory cytokines in sera of colostrum-fed newborn calves. J Vet Med Sci. 2003 Jul;65(7):813-6


  1. Patel K, Kirkpatrick CM. Pharmacokinetic Concepts Revisited - Basic and Applied. Curr Pharm Biotechnol. 2011 May 10. [Epub ahead of print]


  1. Pelkonen, Olavi; Turpeinen, Miia; Raunio, Hannu. In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development: Current Status and Future Directions. Clinical Pharmacokinetics: 2011,Volume 50 - Issue 8 - pp 483-491


  1. Malcolm Rowland[SUP]1[/SUP], Carl Peck[SUP]2[/SUP], andGeoffrey Tucker[SUP]3,4. [/SUP]Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science. Annual Review of Pharmacology and Toxicology, Vol. 51: 45-73 (Volume publication date February 2011) First published online as a Review in Advance on September 8, 2010


  1. Varghese JM, Roberts JA, Lipman J. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin. 2011 Jan;27(1):19-34.


  1. Roberts JA. Using PK/PD to Optimize Antibiotic Dosing for Critically Ill Patients. Curr Pharm Biotechnol. 2011 May 10. [Epub ahead of print]


  1. Edginton AN, Theil FP, Schmitt W, Willmann SWhole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin Drug Metab Toxicol. 2008 Sep;4(9):1143-52


  1. Espié P, Tytgat D, Sargentini-Maier ML, Poggesi I, Watelet JB Physiologically based pharmacokinetics (PBPK). Drug Metab Rev. 2009;41(3):391-407. Review]


  1. Bulitta JB, Landersdorfer CB, Forrest A, Brown SV, Neely MN, Tsuji BT, Louie A . Relevance of Pharmacokinetic and Pharmacodynamic Modelling to Clinical Care of Critically Ill Patients. Curr Pharm Biotechnol. 2011 May 10. [Epub ahead of print]
12. Czock D, Markert C, Hartman B, Keller F. Pharmacokinetics and pharmacodynamics of antimicrobial drugs. Expert Opin Drug Metab Toxicol. 2009 May;5(5):475-87. Review
 
Just pasting the Titles from Pubmed is not enough, you must show where those Journals are electronically provided by giving explicit links to them.

Like Wiley or SD or Springer etc.!

Example:

"Pelkonen, Olavi; Turpeinen, Miia; Raunio, Hannu. In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development: Current Status and Future Directions. Clinical Pharmacokinetics: 2011,Volume 50 - Issue 8 - pp 483-491"

->>> http://www.ingentaconnect.com/content/adis/cpk/2011/00000050/00000008/art00001

!
 
Last edited:
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
To view the content, you need to Sign In or Register.
 
Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock
To view the content, you need to Sign In or Register.
 
[h=2]In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development: Current Status and Future Directions[/h]
To view the content, you need to Sign In or Register.
 
You must log in or register to reply here.
Back
Top